GONAL-F PEN 900

Dosage

Children: Refer to specific drug information for paediatric dosing guidelines, as this will also vary.

Adults: Refer to specific drug information for dosing guidelines, as this will vary widely.

Mechanism of action

The mechanism of action for 'alfa' cannot be defined without specific identification of the drug. Each compound named 'alfa' will have distinct mechanisms, typically involving receptor interaction, enzyme inhibition, or modulation of physiological pathways.

Pharmacodynamics

Pharmacodynamics will vary widely depending on the specific agent referred to as 'alfa'. Generally, pharmacodynamics describes how a drug affects the body, including its therapeutic effects, side effects, and the relationship between drug concentration and effect.

Pharmacokinetics

The pharmacokinetics of 'alfa' would also depend on the particular drug profile, including absorption, distribution, metabolism, and excretion (ADME). Parameters such as bioavailability, half-life, and clearance rates would need to be defined based on the specific agent.

Pregnancy

Consult healthcare provider for risk assessment.

Breast-feeding

Consult healthcare provider for risk assessment.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Infertility due to hypogonadotropic hypogonadism
• Assisted reproductive technologies, such as in vitro fertilization (IVF)
• Ovarian stimulation in women undergoing fertility treatments
• Male infertility due to insufficient spermatogenesis

Dosage

Children: Refer to the BNF for Children for appropriate dosing guidelines in paediatric populations.

Adults: Refer to specific clinical guidelines and the BNF for dosing recommendations based on individual patient factors and treatment protocols.

Mechanism of action

Follitropin acts by binding to and activating the follicle-stimulating hormone receptor (FSHR) on the surface of ovarian granulosa cells and testicular Sertoli cells. This activation leads to a cascade of intracellular signaling pathways that promote the growth and maturation of ovarian follicles in women and stimulate spermatogenesis in men, thus facilitating fertility.

Pharmacodynamics

Follitropin enhances the ovarian response to gonadotropin stimulation, leading to increased estradiol production and follicular growth. In males, it stimulates Sertoli cells to support spermatogenesis. The pharmacodynamic effects of follitropin are dose-dependent, with higher doses generally resulting in a greater biological response, although individual responses may vary based on receptor sensitivity and other factors.

Pharmacokinetics

Follitropin is administered via subcutaneous injection, with peak plasma concentrations occurring approximately 12 to 24 hours post-injection. The half-life of follitropin is approximately 2 to 4 hours, but its biological effects last longer due to the continuous stimulation of the FSH receptor. It is primarily eliminated through renal pathways, and its pharmacokinetic profile can be influenced by factors such as patient age, body weight, and renal function.

Contra-indications

• Hypersensitivity to follitropin or any of its excipients
• Primary ovarian failure
• Pituitary or hypothalamic tumors
• Ovarian cysts or enlarged ovaries not due to polycystic ovary syndrome
• Pregnancy

Adverse effects

• Ovarian hyperstimulation syndrome (OHSS)
• Headache
• Abdominal pain
• Nausea
• Injection site reactions
• Multiple pregnancies
• Breast tenderness

Interactions

• Other gonadotropins may have additive effects
• Hormonal contraceptives may reduce the efficacy of follitropin
• Corticosteroids may affect ovarian response

Precautions

• Use with caution in patients with a history of thromboembolic events
• Monitor for signs of OHSS
• Assess ovarian response carefully during treatment
• Consider patient’s psychological state when undergoing fertility treatment

Pregnancy

Follitropin is contraindicated in pregnancy due to potential risks to the fetus.

Breast-feeding

Limited data available; caution is advised when administering to breastfeeding women.

Storage

Store in a refrigerator (2-8 degrees Celsius), do not freeze. Protect from light.

Formulations

• Follitropin alfa (recombinant)
• Follitropin beta (recombinant)